Cite

HARVARD Citation

    Pieper, N. et al. (2018). Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment. Oncoimmunology. p. . [Online]. 
  
Back to record